Experiments performed in the EG7 tumor model whose successful treatment does not require NK cells [5] clearly show that both the cytolytic granule and the FasL-mediated killing mechanisms were synergistically involved in achieving complete rejections of these lymphomas. The gene discussed is FASLG; the disease is lymphoma.